skip to Main Content

News

Latest News, Announcements, and Press Releases

29Aug 18

Codexis to Present at Three Investment Conferences in September

REDWOOD CITY, Calif. , Aug. 29, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: H.C. Wainwright 20 th Annual Global investment Conference on Wednesday, September 5,…
read more
08Aug 18

Codexis Reports Second Quarter 2018 Financial Results

Total revenues increase 31% to $13.5 million driven by higher R&D revenue Phase 1a clinical trial for CDX-6114 initiated Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , Aug. 08, 2018 (GLOBE NEWSWIRE) — Codexis, Inc.…
read more
29May 18

Codexis to Present at Three Upcoming Investment Conferences

REDWOOD CITY, Calif. , May 29, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: 15 th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 30 ,…
read more
10May 18

Codexis Reports First Quarter 2018 Financial Results

Total revenues increase 76% to $14.0 million on sharply higher R&D revenue Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , May 10, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces…
read more
23Apr 18

Porton Pharma Solutions and Codexis Launch Global Partnership

View translation: Japanese | Simplified Chinese | Traditional Chinese Redwood City, Calif., and Chongqing, China (April 23, 2018) – Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology…
read more
23Apr 18

Porton Pharma Solutions and Codexis Launch Global Partnership

REDWOOD CITY, Calif. & CHONGQING, China –(BUSINESS WIRE)–Apr. 23, 2018– Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins with Codexis

Back To Top
Close search
Search